Trial intelligence / Profile preview

Inhaled Nitric Oxide in Acute Chest Syndrome of Adult Sickle Cell Patients

NCT00748423Phase 3Completed

Sponsor
Assistance publique - Hôpitaux de Paris
Start
Dec 2008
Primary completion
Dec 2012
Modality
DNA Intercalators/Alkylators, Inhalation Devices
Countries
1
01

Overview

A Phase 3 trial of nitric oxide in acute chest syndrome (ACS), sponsored by Assistance publique - Hôpitaux de Paris. Started Dec 2008; status: completed.

02

Drugs

nitric oxide
03

Conditions

acute chest syndrome (ACS)

Beyond the preview

Go deeper on NCT00748423.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00748423.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call